Pell Bio-Med Technology Co., Ltd. (TPE:6949)
Taiwan · Delayed Price · Currency is TWD 562.00
-8.00 (-1.40%)
Apr 2, 2026, 1:30 PM CST
Pell Bio-Med Technology Market Cap
Pell Bio-Med Technology has a market cap or net worth of 36.37 billion as of April 2, 2026. Its market cap has increased by 319.48% in one year.
Market Cap
36.37B
Enterprise Value
36.22B
Revenue
31.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
562.00
Market Cap Chart
Since March 8, 2024, Pell Bio-Med Technology's market cap has increased from 5.56B to 36.37B, an increase of 554.62%. That is a compound annual growth rate of 148.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 36.29B | 80.90% |
| Dec 31, 2025 | 20.06B | 324.81% |
| Dec 31, 2024 | 4.72B | -15.00% |
| Mar 8, 2024 | 5.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lin BioScience | 30.73B |
| Oneness Biotech | 24.93B |
| Lumosa Therapeutics | 24.87B |
| Sunmax Biotechnology | 21.08B |
| Medigen Vaccine Biologics | 18.84B |
| EirGenix | 17.25B |
| AP Biosciences | 16.90B |
| Polaris Group | 16.47B |